treating depression by reducing inflammation

Treating depression by reducing inflammation

June 2, 2026

By Nicolas Gutierrez C. THE Subscribers

This new therapeutic approach to treating depression resistant to traditional treatments, which targets pro-inflammatory proteins, would be effective in patients who have chronic inflammation.

Chronic inflammation could be one of the causes of depression.

Chronic inflammation could be one of the causes of depression.

MATHIEU THOMASSET / HANS LUCAS / HANS LUCAS VIA AFP

What if some depressions were caused by excessive inflammation? The precise causes of this mental illness are difficult to pinpoint, perhaps because they could differ from one patient to another. A low rate of serotonin In some, a lack of noradrenaline or other neurotransmitters (gamma-aminobutyric acid, glutamate, etc.); in others…

Another possible explanation is inflammation: nearly a third of patients have chronic inflammation, with elevated levels of pro-inflammatory proteins, such as interleukin-6. Researchers from the British universities of Bristol and Cambridge, and University College London, tested this hypothesis by treating depression with immunotherapy that targeted these molecules responsible for inflammation. The results, published on May 20, 2026 in JAMA Psychiatry, show that this approach could be effective for some patients.

Depression Resistant depression Immunotherapy

en_USEnglish